Skip to main content
PolicySpeak
← All legislative files
2025/2087(INI)SANT

Public health aspects of biotechnology and life sciences

Stage
Tabled for plenary, reached 19 Dec 2025
Procedure
Own-initiative report
Rapporteur
Margarita de la Pisa Carrión (PfE)
Last activity
19 Dec 2025
5 entries · record as of 12 Oct 2026

Where it stands

Latest: Tabled for plenary, 19 Dec 2025.

  1. 5 May 2025
    • Committee report tabled
  2. 8 May 2025
    • Referred to committee
  3. 17 Jun 2025
    • Committee amendments tabled
  4. 2 Dec 2025
    • Committee report adopted
  5. 19 Dec 2025
    • Tabled for plenary
8 people

Who is on it

The Parliament's rapporteurs, shadow rapporteurs and opinion rapporteurs currently on this file.

RoleNameGroupCountryCommittee
RapporteurMargarita de la Pisa CarriónPfEESSANT
Shadow rapporteurAnja HazekampThe LeftNLSANT
Shadow rapporteurChristine AndersonESNDESANT
Shadow rapporteurIgnazio Roberto MarinoGreens/EFAITSANT
Shadow rapporteurNicolás González CasaresS&DESSANT
Shadow rapporteurOlivier ChastelRenewBESANT
Shadow rapporteurSérgio HumbertoEPPPTSANT
Shadow rapporteurWaldemar BudaECRPLSANT
581 amendments

Amendments

Tabled on 17 Jun 2025. The texts are in the amendment documents below.

By committee

  • SANT581

By author

  • Kristian Vigenin110
  • Leire Pajín110
  • Marta Temido110
  • Nicolás González Casares110
  • Pierre Jouvet110
  • Romana Jerković110
  • Tiemo Wölken110
  • Vytenis Povilas Andriukaitis110
  • Billy Kelleher69
  • Ignazio Roberto Marino61
Show 20 more authors
  • Stine Bosse61
  • Catarina Martins58
  • Sebastian Everding58
  • Anja Hazekamp57
  • Nikos Papandreou53
  • Liesbet Sommen52
  • Sérgio Humberto52
  • Margarita de la Pisa Carrión45
  • Dolors Montserrat43
  • Elena Nevado del Campo43
  • Olivier Chastel43
  • Veronika Cifrová Ostrihoňová43
  • Viktória Ferenc35
  • Aurelijus Veryga28
  • Adam Jarubas26
  • Ondřej Knotek22
  • Bartosz Arłukowicz19
  • Ewa Kopacz19
  • Jessica Polfjärd18
  • Dan-Ştefan Motreanu17

Amendments each member tabled or co-signed, among signers matched to our directory.

By article

  • Paragraph 712
  • Paragraph 21 a (new)10
  • Paragraph 910
  • Paragraph 19
  • Paragraph 139
  • Paragraph 149
  • Paragraph 179
  • Paragraph 22 a (new)9
  • Paragraph 128
  • Paragraph 228
Show 20 more provisions
  • Paragraph 7 a (new)8
  • Paragraph 8 a (new)8
  • Recital D8
  • Paragraph 247
  • Recital J a (new)7
  • Paragraph 10 a (new)6
  • Paragraph 12 a (new)6
  • Paragraph 166
  • Paragraph 26
  • Paragraph 36
  • Paragraph 336
  • Paragraph 46
  • Paragraph 6 a (new)6
  • Paragraph 9 a (new)6
  • Recital B6
  • Recital D a (new)6
  • Recital E6
  • Paragraph 1 a (new)5
  • Paragraph 15 a (new)5
  • Paragraph 16 a (new)5

Covers 218 of the 581 amendments.

4 documents

Documents

Newest first. Each opens at its source.

Summary

Generated

European Parliament report on the public health aspects of biotechnology and life sciences. The file is tabled for plenary, with Margarita de la Pisa Carrión as rapporteur. It covers health-related dimensions of biotech and life sciences policy. No lead DG or commissioner is recorded.

What the workspace adds on this file

Everything above is the public record. In the workspace, subscribers see this file with their own layer on top.

Why it matters to you

What this file means for your organization, assessed against your own priorities.

What moved

When this file moves, it reaches your own briefing, with a link to its source.

Your contacts on it

Your team's contacts logged against this file: who you met, what was said and the next step.

A first draft

A statement, a member update or a meeting brief on this file, in your organization's voice, with its sources.

Sources: EP Legislative Observatory. Record as of 12 Oct 2026. Something wrong on this page? Report an error.

Request access

See this file with your own layer on top: why it matters to you, your contacts on it and a first draft. We’ll schedule a 20-minute walkthrough.

Hosted in the EU · Security →

By submitting, you agree to our privacy policy.